Skip to content

Clinical trials

Completed Neoplasms, Glandular and Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20091
20101
20113
20121
20142
20151
20165
20172
20182
20192
20201
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.3
Merck Sharp & Dohme LLC2
Syndax Pharmaceuticals2
AVEO Pharmaceuticals, Inc.1
Advaxis, Inc.1
Belgian Gynaecological Oncology Group1
Boston Scientific Corporation1
Catalysis SL1
DNAtrix, Inc.1
Dendreon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial28
Neoplasms19
Neoplasms by Histologic Type15
Carcinoma14
Neoplasms by Site13
Digestive System Neoplasms12
Adenocarcinoma11
Digestive System Diseases10
Endocrine Gland Neoplasms7
Urogenital Neoplasms7

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.